G Bradley Cole
CIK 1337798 · General Manager - Diagnostics · last filed 2026-07-31
G Bradley Cole is a General Manager - Diagnostics who has filed 156 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for KNSA, was dated Jul 31, 2026. Across all open-market trades the lifetime net is −$33.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.92M
4
156
-$33.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | Director | 11,672 | $77.37 | $903.1K | -$299.1K | 9 | 2026-07-31 |
| CSTL | Director | 32,976 | $30.87 | $1.02M | -$210.7K | 12 | 2026-06-01 |
| EXACT SCIENCES CORP (EXAS) Delisted | General Manager - Diagnostics | 49,884 | $104.91 | $5.23M | -$5.89M | 4 | 2020-02-21 |
| GENOMIC HEALTH INC (GHDX) Delisted | CFO | 84,342 | — | — | -$27.34M | 128 | 2019-10-09 |
Recent Filings
156 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-31 | KNSA | Mixed | −8,173 | -$299.1K | EDGAR |
| 2026-07-29 | KNSA | Notice (144) | −3,673 | -$299.1K | EDGAR |
| 2026-06-02 | KNSA | Mixed | +2,799 | $0 | EDGAR |
| 2026-06-01 | CSTL | Grant (A) | — | $0 | EDGAR |
| 2026-05-27 | CSTL | Exer (M) | +13,667 | $0 | EDGAR |
| 2026-03-09 | CSTL | Mixed | −2,655 | -$194.7K | EDGAR |
| 2026-03-05 | CSTL | Notice (144) | −7,403 | -$210.7K | EDGAR |
| 2025-06-05 | KNSA | Mixed | +3,173 | $0 | EDGAR |
| 2025-05-23 | CSTL | Mixed | +8,673 | $0 | EDGAR |
| 2024-06-07 | KNSA | Mixed | +4,373 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.